Clinical trials
Terminated Endocarditis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| AbbVie | 1 |
| Abbott Medical Devices | 1 |
| Carmen Olmos Blanco | 1 |
| Corewell Health East | 1 |
| Henry Ford Health System | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Johannes Grand | 1 |
| Maria Vittoria Hospital | 1 |
| University of Santiago de Compostela | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocarditis | 13 |
| Bacteremia | 5 |
| Endocarditis, Bacterial | 4 |
| Gram-Positive Bacterial Infections | 2 |
| Staphylococcal Infections | 2 |
| Aortic Valve Disease | 1 |
| Arthritis, Infectious | 1 |
| Cardiovascular Diseases | 1 |
| Embolism | 1 |
| Infections | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.